Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - P/B ratio
P/B ratio as of May 2024 : 0.1686
According to Bellerophon Therapeutics
's latest financial reports the company has a price-to-book ratio of 0.1686.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Bellerophon Therapeutics - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.1216 | -96.41% |
| 2022-12-31 | 3.39 | 148.71% |
| 2021-12-31 | 1.36 | -17.7% |
| 2020-12-31 | 1.66 | -75.24% |
| 2019-12-31 | 6.69 | -45.14% |
| 2018-12-31 | 12.2 | -122.22% |
| 2017-12-31 | -54.9 | -6087.48% |
| 2016-12-31 | 0.9166 | -28.46% |
| 2015-12-31 | 1.28 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.75 | 2,718.13% | 🇺🇸 USA |
 Baxter BAX | 2.43 | 1,339.55% | 🇺🇸 USA |
 Lantheus Holdings LNTH | 5.66 | 3,259.21% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | 7.21 | 4,180.04% | 🇺🇸 USA |